- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Recombinant SARS-CoV PLpro Protein (aa 1541-1859) (CAT#: VReP-Wyb010)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VReP-Wyb010 |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- SARS-CoV (strain WH20), Recombinant Protein, Papain-like Protease Protein [His].
- Source
- E. coli
- Tag
- His
- Target
- SARS-CoV
- Type
- Viral Antigens
- Applications
- Used for immunoassays.
- Formulation
- 50 mM Tris, 0.1% Tween, pH 9.0.
- Purity
- > 90% pure by SDS-PAGE.
- Product Form
- Lyophilized
- Storage
- Store at -20°C to -80°C.
- Introduction
- The SARS virus belongs to the family Coronavirus. Most of the virus particles are circular, have capsules, and coronal arrayed fibroids are distributed on the periphery. On April 16, 2003, the World Health Organization announced that a variant of the coronavirus was officially confirmed to be the pathogen causing atypical pneumonia. The virus contains at least 5 open reading frames, which respectively encode the matrix sugar M fiber protein E2 or S, the small coat protein E or the SM nucleocapsid protein of the virus.
- Alternative Names
- SARS-CoV; SARS coronavirus; Severe acute respiratory syndrome; Coronaviridae
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.